Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione

Competenze & Professionalità
Logo UNIBS

|

Competenze & Professionalità

unibs.it
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione
  1. Pubblicazioni

Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines

Articolo
Data di Pubblicazione:
2018
Abstract:
Purpose
Ferroptosis is a programmed form of iron-dependent cell death caused by lipid hydroperoxide accumulation, which can
be prevented by glutathione peroxidase 4 (GPx4) activity. Here we investigated the effects of ferroptosis inducers called
erastin and RSL3, which act by glutathione depletion and GPx4 inactivation, respectively, on muscle-derived cell lines
of embryonal and alveolar rhabdomyosarcoma (RMS), and mouse normal skeletal C2C12 myoblasts.
Methods
Myogenic lines were exposed to stepwise increasing concentrations of ferroptosis inducers either alone or in
combination with iron supplementation, iron chelating agents (Bathophenanthrolinedisulfonic acid, BPS), antioxidant
molecules (glutathione, N-acetylcysteine), lipid peroxidation inhibitors (Ferrostatin-1), and chemotherapeutic agents
(doxorubicin and actinomycin D). Drug susceptibility was quantified by measuring cell viability, proliferation and
differentiation via neutral red assay, crystal violet assay and Giemsa staining, respectively. The detection of lipid
hydroperoxide and protein levels was performed by immunofluorescence and Western blot analysis, respectively.
Results
Erastin and RSL3 increased lipid hydroperoxide levels preferentially in the embryonal U57810 and myoblast C2C12
lines, leading to ferroptosis that was accentuated by iron supplementation or prevented by co-treatment with BPS,
glutathione, N-acetylcysteine and Ferrostatin-1. The inhibition of extracellular regulated kinases (ERK) pathway
prevented ferroptosis in U57810 and C2C12 cells, whereas its increased activation in the embryonal RD cells mediated
by Caveolin-1 (Cav-1) overexpression led to augmented ferroptosis susceptibility. Finally, we observed the combination
of erastin or RSL3 with chemotherapeutic doxorubicin and actinomycin D agents to be effective in increasing cell death
in all RMS lines.
Conclusions
Erastin and RSL3 prime to ferroptosis rapidly dividing myogenic lines through a ERK pathway-dependent fashion.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Erastin; Ferroptosis; GPx4; Iron; RSL3; Rhabdomyosarcoma
Elenco autori:
Codenotti, Silvia; Poli, Maura; Asperti, Michela; Zizioli, Daniela; Marampon, Francesco; Fanzani, Alessandro
Autori di Ateneo:
Biochimica cellulare dei tumori dei tessuti molli
FANZANI ALESSANDRO
POLI MAURA
ZIZIOLI DANIELA
Link alla scheda completa:
https://iris.unibs.it/handle/11379/508972
Pubblicato in:
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Journal
  • Assistenza
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Designed by Cineca | 26.5.2.0